SA
Go ProLog In
CV
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
1 analyst·Low coverage
75
Score
1 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$7.00
+11.6%
Consensus
$81.50
+1198.8%
Bull
$156.00
+2386.1%
12-Month Target Range1 analyst
$7.00$81.50$156.00
Current $6.28Consensus
Current Price
$6.28
Upside to Consensus
$75.22

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+37.88%
EPS—
FY2028
Rev+146.80%
EPS—
FY2029
Rev+85.85%
EPS+143.75%

Earnings Surprises

Recent Analyst Actions

Nov 4, 2025Roth Capital
CapsoVision resumed with a Buy at Roth Capital
Target:$7.00
+46.4%from $4.78
Jul 28, 2025Roth Capital
CapsoVision initiated with a Buy at Roth Capital
Target:$6.00
+50.0%from $4.00
May 30, 2024Raymond James
Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead: Goldman Sachs
Target:$156.00
0

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance